$1.61
+0.04 (+2.55%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,546.6% upside
Low Target
$22.54
Average Target
$42.61
High Target
$49.20
Current Price
$1.61
Current
$1.61
$1.61
Target
$42.61
$42.61
$22.54
$42.61 avg
$49.20
Scenario Analysis
Bear Case
$22.54
1,300.0%
Low target
Base Case
$42.61
+2,546.6%
Avg target
Bull Case
$49.20
+2,955.9%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.56
-54.8% from high
52-Week Low
$1.27
+26.8% from low
Target vs 52W High
$42.61
+1,096.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |